|
19/09/2024
|
15:17
|
Notice of Results
|
RNS
|
|
11/09/2024
|
07:00
|
Arecor presents positive AT278 data at EASD
|
RNS
|
|
22/08/2024
|
16:34
|
Holding(s) in Company
|
RNS
|
|
20/08/2024
|
13:44
|
Holding(s) in Company
|
RNS
|
|
12/08/2024
|
15:02
|
Holding(s) in Company
|
RNS
|
|
08/08/2024
|
14:48
|
Result of General Meeting and Total Voting Rights
|
RNS
|
|
23/07/2024
|
16:26
|
Posting of Circular and General Meeting
|
RNS
|
|
23/07/2024
|
07:00
|
Result of WRAP Retail Offer
|
RNS
|
|
19/07/2024
|
18:22
|
Result of Placing and Subscription
|
RNS
|
|
19/07/2024
|
13:17
|
WRAP Retail Offer to raise up to £1 million
|
RNS
|
|
19/07/2024
|
13:10
|
Proposed Placing and Subscription
|
RNS
|
|
28/06/2024
|
14:35
|
Result of AGM
|
RNS
|
|
10/06/2024
|
07:00
|
Trading and Funding Update
|
RNS
|
|
31/05/2024
|
16:05
|
Posting of 2023 Annual Report and Notice of AGM
|
RNS
|
|
23/05/2024
|
07:00
|
Grant of Options and PDMR Dealing
|
RNS
|
|
21/05/2024
|
07:00
|
Arecor to host company and KOL webinar today
|
RNS
|
|
20/05/2024
|
07:00
|
Positive headline results for AT278 clinical trial
|
RNS
|
|
16/05/2024
|
07:00
|
Final results for 2023
|
RNS
|
|
14/05/2024
|
10:17
|
Notice of Results
|
RNS
|
|
09/05/2024
|
07:00
|
Arecor and Medtronic Diabetes collaboration
|
RNS
|
|
03/05/2024
|
16:44
|
Publication of Full Year Financial Results delayed
|
RNS
|
|
29/04/2024
|
07:00
|
Notice of results
|
RNS
|
|
23/04/2024
|
07:00
|
BOARD CHANGE
|
RNS
|
|
12/03/2024
|
08:58
|
Arecor and TRx Biosciences research collaboration
|
RNS
|
|
29/02/2024
|
07:00
|
Arecor announces launch of Ogluo® in Netherlands
|
RNS
|
|
01/02/2024
|
07:00
|
Year End Trading Update
|
RNS
|
|
23/01/2024
|
16:58
|
Arecor announces update on INBRX-101
|
RNS
|
|
18/01/2024
|
07:00
|
Arecor granted key European patent
|
RNS
|
|
08/01/2024
|
07:00
|
Expansion of specialty hospital collaboration
|
RNS
|
|
03/01/2024
|
07:00
|
Appointment of SVP for Tetris Pharma Ltd
|
RNS
|
|
04/12/2023
|
07:00
|
Agreement with global medical products company
|
RNS
|
|
29/11/2023
|
07:00
|
Arecor Continues Collaboration with Lilly
|
RNS
|
|
17/11/2023
|
07:00
|
Product with Arestat technology launched in Europe
|
RNS
|
|
02/11/2023
|
07:00
|
Inhibrx milestone triggers payment to Arecor
|
RNS
|
|
01/11/2023
|
15:31
|
Exercise of rollover options & Total Voting Rights
|
RNS
|
|
02/10/2023
|
07:00
|
Progress of Phase I clinical study of AT278
|
RNS
|
|
14/09/2023
|
07:00
|
Interim Results for six months ended 30 June 2023
|
RNS
|
|
07/09/2023
|
07:00
|
Arecor: positive Hikma FDA pre-IND meeting
|
RNS
|
|
17/08/2023
|
07:00
|
Collaboration With Top 10 Global Pharma
|
RNS
|
|
10/08/2023
|
07:00
|
Notice of Interim Results
|
RNS
|
|
20/07/2023
|
07:00
|
Arecor Business Update
|
RNS
|
|
05/07/2023
|
07:00
|
Additional Agreement with Leading Biopharma
|
RNS
|
|
27/06/2023
|
07:00
|
Arecor granted key patents in Europe and China
|
RNS
|
|
09/06/2023
|
15:35
|
Exercise of rollover options & Total Voting Rights
|
RNS
|
|
09/06/2023
|
12:43
|
Result of AGM
|
RNS
|
|
09/06/2023
|
07:00
|
AGM Statement
|
RNS
|
|
24/05/2023
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
04/05/2023
|
16:00
|
ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
|
RNS
|
|
26/04/2023
|
07:00
|
Arecor Granted Key U.S Patent
|
RNS
|
|
20/04/2023
|
07:00
|
Unaudited Preliminary Results for 2022
|
RNS
|